IBM is fully committed to leading this new era. In fact, our commitment to the acceleration of SaaS is definitively seen through our acquisitions, our software offerings, and our partner resources. Our strategic acquisitions of Apptio and HashiCorp, combined with the strength of Red Hat and watsonx, have created a powerful ecosystem of hybrid cloud and AI-driven SaaS solutions. These platforms enable enterprises to integrate, automate, and secure complex operations across diverse environments — key for building future-proof, cloud-native applications.
This month IBM is radically simplifying the enterprise data stack, introducing software that unifies, governs, and activates the unstructured enterprise data necessary to power AI agents and other advanced AI applications.
IBM today announced watsonx AI Labs, a new, developer-first innovation hub in New York City, designed to supercharge AI builders and accelerate AI adoption at scale. watsonx AI Labs connects IBM's enterprise resources and expertise with the next generation of AI developers in order to build breakthrough AI applications for business.
IBM and Roche used their collective innovation power and have developed an AI-enabled solution to ease the daily diabetes management: Roche’s Accu-Chek® SmartGuide Predict app. This solution underpins the importance of cross-industry collaboration and teamwork to support people with diabetes in their daily lives and the provision of healthcare.
IBM Unveils watsonx AI Labs: The Ultimate Accelerator for AI Builders, Startups and Enterprises in New York City
IBM and Roche Co-Created an Innovative Solution to Support People with Diabetes in their Daily Lives with AI-Enabled Glucose Predictions